October 24, 2020

The Niche

Knoepfler lab stem cell blog


2 min read

It was my pleasure recently to  talk at length with Dr. Michael West, CEO of the Stem Cell Biotech, BioTime (BTX). West has been at the helm of BioTime since 2007 and is a true pioneer in the stem cell field. He founded Geron (GERN) and was a top leader at Advanced Cell Technology (ACT; stock symbol ACTC) in the early days. He contributed to the team that made human embryonic stem cells (hESC) a reality too. West and I talked at length about the …Read More

3 min read

What are Conflict of Interests (COI)? The term COI is sometimes used inappropriately as a weapon by one party to attempt to discredit others. We see this more and more frequently in the stem cell field with boosters of for-profit, non-FDA vetted adult stem cell clinics attacking scientists for supposed COIs for what…..apparently for simply being a stem cell scientist. Onlookers may be confused about this. Being an interested party or having an interest in a general sense in something like stem cells is …Read More

3 min read

Today after years of following the company Advanced Cell Technology (ACT), I finally bought stock (ACTC) in it. Why? As a stem cell researcher myself working on human ES cells, iPS cells, and many other types of stem cells, I have been following ACT for years, but have never pulled the trigger to buy their stock….until now. They are conducting research on using human ES cell-based technology as treatments for blindness. They are also currently the only company with FDA approved clinical trials underway. At …Read More